SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950162-14-000042
Filing Date
2014-07-11
Accepted
2014-07-11 15:45:18
Documents
1
Group Members
CLARKE B. FUTCHGREGORY B. BROWN MDHCRP OVERFLOW GP LLCHEALTHCARE ROYALTY GP II LLCHEALTHCARE ROYALTY MANAGEMENT LLCHEALTHCARE ROYALTY PARTNERS II L.P.MOLAG HEALTHCARE ROYALTY LLCTODD C. DAVISVANDERBILT ACCOUNT MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 RAPTOR PHARMACEUTICAL CORP. (AS ISSUER) SCHEDULE 13G DATED JULY 1, 2014 sc13g.htm SC 13G 243220
  Complete submission text file 0000950162-14-000042.txt   245414
Mailing Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949
Business Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Subject) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60719 | Film No.: 14971645
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 ATLANTIC STREET SUITE 600 STAMFORD CT 06901
Business Address 300 ATLANTIC STREET SUITE 600 STAMFORD CT 06901 203.388.9080
HCRP OVERFLOW FUND, L.P./SERIES B (Filed by) CIK: 0001609240 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G